Impact of hypertension, overweight, hypertriglyceridemia and their combination for mortality rate according to the results of a 27-year cohort prospective study

Aim. To study influence of hypertension, overweight, hypertriglyceridemia and their combinations for all-cause and cardiovascular mortality risk formation. Methods. The prevalence of hypertension, overweight and hypertriglyceridemia was studied (1988-1991) by 27-year prospective cohort study of unorganized population of Tomsk (1546 persons – 916 female and 630 male). The predictive value of these risk factors for all-cause and cardiovascular mortality risk formation were researched in 2015. Hypertension was diagnosed in persons with blood pressure greater or equal to 140/90 mm Hg, overweight was diagnosed in people with body mass index 25 kg/m², hypertriglyceridemia was diagnosed in individuals having high blood level of triglycerides (greater or equal to 1.7).  Results.  Influence of hypertension for all-cause (relative risk (RR) 2.2) and cardiovascular mortality (RR 3.38) risk formation was detected. A hypertension related elevation of mortality risk was observed both among women and men and in all age groups with the exception of men 40-59 years (the results for cardiovascular mortality in these persons was statistically insignificant). We established that hypertension had the independent significant contribution for mortality risk formation. It is shown that RR of all-cause mortality 1.25 times (cardiovascular mortality 1.8 times) more in overweight persons. Increase of relative mortality risk was detected in overweight women, especially in women 20-39 years old. Hypertriglyceridemia increases relative risk of all-cause mortality 1.46 times, relative risk of cardiovascular mortality 2.15 times, especially in individuals 40-59 years old. It was revealed that hypertriglyceridemia is significant risk factor for all-cause mortality formation only in women. Combination of hypertension and overweight increases the risk of all-cause mortality 2.23 times and the risk of cardiovascular mortality  4.0 times, combination of hypertension and hypertriglyceridemia – 2.83 and 5.06 times,  combination of overweight and hypertriglyceridemia – 1.73 and 2.99 times, respectively. We detected the additional risk of hypertriglyceridemia in individuals with overweight for all-cause (RR 1.53) and cardiovascular (RR 2.18) mortality risk formation compared with overweight persons with normal level of triglycerides and also the additional risk of hypertriglyceridemia (RR 1.51 and 2.04, respectively) in individuals with hypertension compared with normotensive persons (p<0,05). The additional risk of overweight in individuals with hypertension for all-cause mortality was found only in women (RR 3.23). Conclusion. The independent significant impact of hypertension for all-cause and cardiovascular mortality risk formation was revealed by the results of 27-year prospective study. Combination of hypertension and hypertriglyceridemia increases the risk of all-cause mortality 2.8 times and the risk of cardiovascular mortality 5.1 times, combination of hypertension and overweight – 2.2 and 4 times, combination of overweight and hypertriglyceridemia – 1.7 and 3 times, respectively. We detected the additional risk of hypertriglyceridemia for all-cause mortality in overweight people (RR 1.5) and in individuals with hypertension (RR 1.5). Also, the additional risk of hypertriglyceridemia for cardiovascular mortality risk formation in overweight people (RR 2.2) and in persons with hypertension (RR 2.0) was found.

1. World Health Organization. Cardiovascular diseases (CVDs). 2017. [Internet] 2017. Available at: https://www.who.int/news-room/factsheets/detail/cardiovascular-diseases-(cvds)

2. World Health Organization. A global brief of hypertension. Silent killer, global public health crisis. World health day. 2013. [Available at: http://ish-world.com/downloads/pdf/global_brief_hypertension.pdf]

3. Maslennikova G.Ya., Oganov R.G., Axelrod S.V., Boytsov S.A. Reducing mortality from cardiovascular and other non-communicable diseases in economies with high per capita income: the activity of not government institutions. Cardiovascular Therapy and Prevention. 2015;14(6):5–9. DOI: 10.15829/1728-8800-2015-6-5-9

4. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. -Geneva: World Health Organization;2015. - 70 p. ISBN 978-92-4-456387-8

5. World Health Organization. Obesity and overweight. 2018. [Internet] 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

6. Soboleva N.P., Rudnev S.G., Nikolayev D.V., Eryukova T.A., Kolesnikov V.A., Melnitchneko O.A. et al. The bio-impedance screening of population in health centers: prevalence of surplus body mass and obesity. Russian Medical Journal. 2014;20(4):4–13.

7. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. Heart Disease and Stroke Statistics—2016 Update: A Report from the American Heart Association. Circulation. 2016;133(4):e38–360. DOI: 10.1161/CIR.0000000000000350

8. Liu J, Zeng F-F, Liu Z-M, Zhang C-X, Ling W, Chen Y-M. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids in Health and Disease. 2013;12(1):159. DOI: 10.1186/1476-511X-12-159

9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97. PMID: 11368702

10. Karpov Yu.A. Study Prevalence of Hypertriglyceridemia: New Data Across the Russian Population. The PROMETHEUS Study. Kardiologiia. 2016;56(7):63–71. DOI: 10.18565/cardio.2016.7.63-71

11. Ezhov M.V., Sergienko I.V., Aronov D.M., Arabidze G.G., Akhmedzhanov N.M., Bazhan S.S. et al. Diagnostics and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Revision VI. Atherosclerosis and Dyslipidemias. 2017;3(28):5–22.

12. Ivanova A.Yu., Dolgalev I.V. Impact of Arterial Hypertension on the Formation of the Risk of Mortality. Results of a 27-Year Prospective Study. Kardiologiia. 2018;17(9):5–11. DOI: 10.18087/cardio.2018.9.10168

13. Ivanova A.Yu., Dolgalev I.V. Impact of overweight and obesity on mortality (according to the results of a 27-year prospective study). Preventive Medicine. 2017;20(3):34–9. DOI: 10.17116/profmed201720334-39

14. Pannier B, Thomas F, Hanon O, Czernichow S, Lemogne C, Simon T et al. Individual 6-year systolic blood pressure change and impact on cardiovascular mortality in a French general population. Journal of Human Hypertension. 2016;30(1):18–23. DOI: 10.1038/jhh.2015.44

15. Sepanlou SG, Sharafkhah M, Poustchi H, Malekzadeh MM, Etemadi A, Khademi H et al. Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. Journal of Human Hypertension. 2016;30(4):260–7. DOI: 10.1038/jhh.2015.57

16. Dolgalyov I.V., Obraztsov V.V., Tsimbalyuk I.V., Konko T.Yu., Trotsenko B.A., Karpov R.S. Dynamics of arterial hypertension depending on change of weight of a body, according to the results of a 17-year prospective study. Bulletin of Siberian Medicine. 2012;11(1):150–5.